1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Gut hormone-based pharmacology : novel formulations and future possibilities for metabolic disease therapy
(
- Contribution to journal › Scientific review
- 2017
-
Mark
High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial
(
- Contribution to journal › Article
- 2014
-
Mark
Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
(
- Contribution to journal › Article
- 2012
-
Mark
Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models
(
- Contribution to journal › Article
- 2007
-
Mark
Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.
(
- Contribution to journal › Article
-
Mark
GPR40 is expressed in glucagon producing cells and affects glucagon secretion.
(
- Contribution to journal › Article
- 2005
-
Mark
Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker diabetic fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV
(
- Contribution to journal › Article
- 2004
-
Mark
The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice
(
- Contribution to journal › Article
- 2003
-
Mark
Local growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats
(
- Contribution to journal › Article